• SARS-CoV-2 Antigen kit1
  • SARS-CoV-2 Antigen kit
  • SARS-CoV-2 IgGIgM Rapid Test
StrongStep® SARS-CoV-2 Antigen Rapid Test Enter the EU common list of hygiene and food safety, which is one of the few manufacturers that has 100% sensitivity when the CT value is less than 25%.

StrongStep® SARS-CoV-2 Antigen Rapid Test Enter the EU common list of hygiene and food safety

StrongStep® SARS-CoV-2 Antigen Rapid Test Enter the EU common list of hygiene and food safety, which is one of the few manufacturers that has 100% sensitivity when the CT value is less than 25%.
StrongStep® SARS-CoV-2 Antigen Rapid Test ncluded in the FIND evaluation list. The Foundation for Innovative New Diagnostics (FIND), is an organization that specializes in evaluating the performance of kits in strategic cooperation with WHO.

StrongStep® SARS-CoV-2 Antigen Rapid Test included in the FIND evaluation list

StrongStep® SARS-CoV-2 Antigen Rapid Test ncluded in the FIND evaluation list. The Foundation for Innovative New Diagnostics (FIND), is an organization that specializes in evaluating the performance of kits in strategic cooperation with WHO.
SARS-CoV-2 has now evolved several mutations with serious consequences,some like B.1.1.7,B.1.351,B.1.2,B.1.1.28,B.1.617,Including the omicron mutant strain(B1.1.529) reported in recent days.
As an IVD reagent manufacturer, we always pay attention to the development of relevant events, check the changes of relevant amino acids and evaluate the possible impact of mutations on reagents.

In Silico Analysis for StrongStep® SARS-CoV-2 Antigen Rapid Test on Different SARS-CoV-2 Variant-1

SARS-CoV-2 has now evolved several mutations with serious consequences,some like B.1.1.7,B.1.351,B.1.2,B.1.1.28,B.1.617,Including the omicron mutant strain(B1.1.529) reported in recent days. As an IVD reagent manufacturer, we always pay attention to the development of relevant events, check the changes of relevant amino acids and evaluate the possible impact of mutations on reagents.
Sequence alignment analysis showed that the mutation site of the SARS-CoV-2 variant observed in the in the United Kingdom , South Africa and India are all not in the design region of the primer and probe at present.
StrongStep® Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit (detection for three genes) can cover and detect mutant strains ( shown in the following table) without affecting the performance at present. Because there is no change in the region of the detection sequence.

Statement on variant viruses

Sequence alignment analysis showed that the mutation site of the SARS-CoV-2 variant observed in the in the United Kingdom , South Africa and India are all not in the design region of the primer and probe at present. StrongStep® Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit (detection for three genes) can cover and detect mutant strains ( shown in the following table) without affecting the performance at present. Because there is no change in the region of the detection sequence.
We have received many certificate or EUA from different countries, such as United Kingdom, Singapore, Brazil, South Africa, Malaysia,Indonesia,Philippine, Argentine, Guatemala and so on.
Also, we have send our products to many institue for evaluation, below are the summary of some data. Please contact us via guangming@limingbio.com if you need full artical of following report.

Summarize of Evaluation Report from Different Institute on StrongStep® SARS-CoV-2 Antigen Rapid Test

We have received many certificate or EUA from different countries, such as United Kingdom, Singapore, Brazil, South Africa, Malaysia,Indonesia,Philippine, Argentine, Guatemala and so on. Also, we have send our products to many institue for evaluation, below are the summary of some data. Please contact us via guangming@limingbio.com if you need full artical of following report.
Recently, the StrongStep® SARS-CoV-2 Antigen Rapid Test produced by Nanjing Liming Bio-products Co. Ltd has successfully obtained the Thailand FDA certificate (registration number T 6400429,T 6400430,T 6400431,T 6400432 ), and now has been approved to enter the Thailand market.

Thailand FDA COVID 19 ATK 2021 T6400429

Recently, the StrongStep® SARS-CoV-2 Antigen Rapid Test produced by Nanjing Liming Bio-products Co. Ltd has successfully obtained the Thailand FDA certificate (registration number T 6400429,T 6400430,T 6400431,T 6400432 ), and now has been approved to enter the Thailand market.
Recently, Nanjing LimingBio‘s Novel Coronavirus (SARS-CoV-2) antigen detection reagent

StrongStep® SARS-CoV-2 Antigen Rapid Test has obtained the performance verification of Paul-Ehrlich-Institut (PEI) in Germany!

Recently, Nanjing LimingBio‘s Novel Coronavirus (SARS-CoV-2) antigen detection reagent "StrongStep® SARS-CoV-2 Antigen Rapid Test" has obtained the performance verification of Paul-Ehrlich-Institut (PEI*) in Germany, this product has been certified by the German Federal Agency for Medicines and Medical Device Administration (BfArM). LimingBio has become one of the few manufacturers in China that has obtained the dual certification of BfArM+PEI in Germany. The Liming Bio's antigen rapid test has passed the authoritative certification of the Ministry of Health of many countries, which fully proves the excellent performance of the kit.
StrongStep® SARS-CoV-2 Antigen Rapid Test is a rapid immunochromatographic assay for the detection of COVID-19 antigen to SARS-CoV-2 virus in human Throat/Nasopharyngeal swab.

SARS-CoV-2 Antigen Rapid Test

StrongStep® SARS-CoV-2 Antigen Rapid Test is a rapid immunochromatographic assay for the detection of COVID-19 antigen to SARS-CoV-2 virus in human Throat/Nasopharyngeal swab.
This highly sensitive, ready-to-use PCR kit is available in lyophilized format (freeze-drying process) for long-term storage. The kit can be transported and stored at room temperature and is stable for one year.

Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit

This highly sensitive, ready-to-use PCR kit is available in lyophilized format (freeze-drying process) for long-term storage. The kit can be transported and stored at room temperature and is stable for one year.

OUR LATEST PRODUCTS

ABOUT US

Nanjing Liming Bio-products Co., Ltd. founded in 2001, our company has been specialized in developing, manufacturing and marketing rapid tests for infectious diseases especially STDs. Apart from ISO13485, nearly all of our products are CE marked and CFDA approved. Our products have shown similar performance compared to other methods (including PCR or culture) which are time-consuming and costly. Using our rapid tests, either patient or healthcare professionals can save a lot of time for waiting because it just needs 10 minute.

SUBSCRIBE